ICD-10 · PDGM grouping
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified
All 6 codes in the Q97 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
6
Can lead a claim
6
Cannot lead a claim
0
What CMS assigns to Q97
All 6 codes group to MMTA - Other. None of the 6 is assigned a comorbidity subgroup. Every code can lead a claim.
Every code in Q97
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| Q97.0 | Karyotype 47, XXX | Can lead a claim | A | None |
| Q97.1 | Female with more than three X chromosomes | Can lead a claim | A | None |
| Q97.2 | Mosaicism, lines with various numbers of X chromosomes | Can lead a claim | A | None |
| Q97.3 | Female with 46, XY karyotype | Can lead a claim | A | None |
| Q97.8 | Other specified sex chromosome abnormalities, female phenotypeCMS: Oth sex chromosome abnormalities, female phenotype | Can lead a claim | A | None |
| Q97.9 | Sex chromosome abnormality, female phenotype, unspecified | Can lead a claim | A | None |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue